Effect of Gemfibrozil ± Niacin ± Cholestyramine on Endothelial Function in Patients With Serum Low-Density Lipoprotein Cholesterol Levels <160 mg/dl and High-Density Lipoprotein Cholesterol Levels <40 mg/dl

This publication has 15 references indexed in Scilit:

• Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
  Circulation, 1995
• The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion
  New England Journal of Medicine, 1995
• Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease
  New England Journal of Medicine, 1995
• Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
  Journal of the American College of Cardiology, 1994
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
  Circulation, 1994
• Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.
  Journal of Clinical Investigation, 1994
• Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
  Circulation, 1993
• Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents
  Journal of the American College of Cardiology, 1993
• Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
  The Lancet, 1993
• Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
  The Lancet, 1992